LivaNova

LivaNova PLC is a global medical device manufacturer founded in 1987 that specializes in designing and developing therapeutic solutions for complex clinical conditions. The company operates through three primary business segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. Its Cardiopulmonary division produces essential equipment such as oxygenators, heart-lung machines, and autotransfusion systems, while the Neuromodulation segment focuses on the VNS Therapy System, an implantable pulse generator designed to treat drug-resistant epilepsy and difficult-to-treat depression. Learn about LivaNova PLC's global headquarters for more information on their international operational footprint.

With a workforce of 1,000-5,000 employees, LivaNova PLC maintains a robust presence across 18 global locations. The company serves a diverse client base including perfusionists, neurosurgeons, and hospitals, utilizing both direct sales representatives and independent distributors to reach medical institutions worldwide. Their Advanced Circulatory Support segment further expands their portfolio by providing temporary life support products, reinforcing their commitment to critical care innovation. Meet LivaNova PLC's team to understand the leadership driving these specialized medical technology advancements.

LivaNova PLC, which trades under the ticker NASDAQ: LIVN, continues to compete in the highly regulated medical device market against major industry players like Penumbra, Terumo BCT, and Masimo. By focusing on high-specification medical technology and clinical testing, the company maintains a competitive edge in the global healthcare sector. Their strategic focus remains on improving patient outcomes through advanced engineering and specialized therapeutic devices, ensuring sustained relevance in the evolving medical landscape.